Merck & Company, Inc. (new) (MRK): Price and Financial Metrics


Merck & Company, Inc. (new) (MRK)

Today's Latest Price: $83.38 USD

1.21 (1.47%)

Updated Jan 15 7:00pm

Add MRK to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 239 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

MRK Stock Summary

  • Merck & Co Inc's market capitalization of $207,892,929,688 is ahead of 99.22% of US-listed equities.
  • Merck & Co Inc's stock had its IPO on January 1, 1986, making it an older stock than 92.8% of US equities in our set.
  • The volatility of Merck & Co Inc's share price is greater than that of just 0.3% US stocks with at least 200 days of trading history.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Merck & Co Inc are NVS, PFE, CSCO, NFLX, and ADBE.
  • Visit MRK's SEC page to see the company's official filings. To visit the company's web site, go to www.merck.com.

MRK Stock Price Chart Interactive Chart >

Price chart for MRK

MRK Price/Volume Stats

Current price $83.38 52-week high $92.06
Prev. close $82.17 52-week low $65.25
Day low $81.56 Volume 9,736,200
Day high $83.50 Avg. volume 10,235,970
50-day MA $81.22 Dividend yield 3.12%
200-day MA $80.54 Market Cap 210.95B

Merck & Company, Inc. (new) (MRK) Company Bio


Merck & Company offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infection, fungal infections, intra-abdominal infections, hypertension, arthritis and pain, inflammatory, osteoporosis, male pattern hair loss, and fertility diseases. The company was founded in 1891 and is based in Kenilworth, New Jersey.


MRK Latest News Stream


Event/Time News Detail
Loading, please wait...

MRK Latest Social Stream


Loading social stream, please wait...

View Full MRK Social Stream

Latest MRK News From Around the Web

Below are the latest news stories about Merck & Co Inc that investors may wish to consider to help them evaluate MRK as an investment opportunity.

Pharma Stock Roundup: LLY's Alzheimer Disease Data, NVS & SNY's M&A Deals

Lilly's (LLY) candidate, donanemab shows slowing of cognitive decline in Alzheimer's disease patients. Novartis (NVS) and Sanofi (SNY) announce M&A deals.

Yahoo | January 15, 2021

Merck (MRK) Stock Moves -0.21%: What You Should Know

Merck (MRK) closed at $82.17 in the latest trading session, marking a -0.21% move from the prior day.

Yahoo | January 14, 2021

Beigene Stock Breaks Out To Record High On Cancer Drug OK In China

Beigene stock broke out and surged to a record high Thursday after China's regulators approved its lung cancer treatment. Earlier this week, Novartis signed on to commercialize the drug.

Yahoo | January 14, 2021

Merck (MRK) Gets Priority Tag for Pneumococcal Vaccine BLA

Merck's (MRK) investigational 15-valent pneumococcal conjugate vaccine, V114 includes pneumococcal serotypes 22F and 33F, which are not included in the currently licensed conjugate vaccines.

Yahoo | January 13, 2021

Merck & Co., Inc. (MRK) CEO Ken Frazier Presents at 39th Annual JPMorgan Healthcare Conference (Transcript)

Merck & Co., Inc. (MRK) 39th Annual JPMorgan Healthcare Conference Call January 11, 2021 16:30 ET Company Participants Ken Frazier - Chairman and Chief Executive Officer Rob Davis - Chief Financial Officer Dean Li - President Conference Call Participants Chris Schott - JPMorgan Presentation Chris Schott Good afternoon, everybody. I...

SA Transcripts on Seeking Alpha | January 12, 2021

Read More 'MRK' Stories Here

MRK Price Returns

1-mo 4.84%
3-mo 6.82%
6-mo 7.30%
1-year -5.43%
3-year 48.99%
5-year 88.75%
YTD 1.93%
2020 -7.20%
2019 22.27%
2018 39.95%
2017 -1.49%
2016 15.05%

MRK Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full MRK Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8508 seconds.